Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safetyWei Wei, Rong Guo, Pei‐En Jian et al.|癌症：英文版|2018Cited by 189
Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular CarcinomaJie Mei, Rong Guo, Wei Wei et al.|Frontiers in Oncology|2021Cited by 127
Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: An interim analysis of a multi-center, phase 3, randomized, controlled clinical trial.Shaohua Li, Rong Guo, Chong Zhong et al.|Journal of Clinical Oncology|2021Cited by 30
Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factorsShu-Hong Li, Lie Zheng, Wei Wei et al.|Medical Oncology|2013Cited by 28
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosisMei Lan, Tai‐Xiang Lu, Chunyan Chen et al.|Scientific Reports|2017Cited by 17